you are viewing a single comment's thread.
This is likely to be a long and bloody fight. Years I suspect. Why don't you teach Steve Anderson some manners?Here's the CRY deal though.BioGlue is where they get their current earnings. CRY is going to be kicked in the groin when it comes to protecting their BioGlue market.Now, SGA has poisoned the HemoStase well too. CRY has about 10 to 12 good quarters before the $hit hits the fan for them.All pretty stupid though, since both companies could get along and thereby both would benefit. Now the attorneys win.